Furthermore, evidence of an association of CD133 expression with ovarian cancer morphology was reported by Zhang et al., (2012), in which HGSC entities expressed this protein higher than LGSC and other malignant ovarian tumors of epithelial origin. This evidence concerns the gene PROM1 and ovarian carcinoma.